Details for New Drug Application (NDA): 006403
✉ Email this page to a colleague
NDA 006403 describes PRISCOLINE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the PRISCOLINE profile page.
The generic ingredient in PRISCOLINE is tolazoline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tolazoline hydrochloride profile page.
The generic ingredient in PRISCOLINE is tolazoline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tolazoline hydrochloride profile page.
Summary for 006403
| Tradename: | PRISCOLINE |
| Applicant: | Novartis |
| Ingredient: | tolazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006403
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
| Approval Date: | Feb 22, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
